Back | Next |
home / stock / swtx / swtx message board
Subject | By | Source | When |
---|---|---|---|
$2.40 getting hit | MWM | investorshub | 10/12/2010 7:45:47 PM |
Slow and Steady wins the race! | MWM | investorshub | 10/11/2010 6:44:53 PM |
About the Empire State Building Retrofit | MWM | investorshub | 10/08/2010 5:04:24 PM |
In a tree by the brook there is | MWM | investorshub | 10/08/2010 3:32:50 PM |
Chart has me humming Stairway to Heaven.... | aries4747 | investorshub | 10/08/2010 3:30:35 PM |
No Split, does not look like they are | MWM | investorshub | 10/08/2010 3:29:26 PM |
Grrrr, wish I had held onto this now... | BSWB | investorshub | 10/08/2010 3:26:58 PM |
$2.40! | MWM | investorshub | 10/08/2010 3:25:05 PM |
MWRI has been a very large buyer over | MWM | investorshub | 10/08/2010 3:10:08 PM |
$SWTX looking for more today... | MWM | investorshub | 10/08/2010 2:11:55 PM |
Decent earnings, some large projects under their wings, | MWM | investorshub | 10/06/2010 7:36:42 PM |
Guess I should actually do some DD, eh? | aries4747 | investorshub | 10/06/2010 7:34:56 PM |
I grabbed a few more at $2.05 myself today! | MWM | investorshub | 10/06/2010 7:33:51 PM |
Bought it on the chart alone right before | aries4747 | investorshub | 10/06/2010 7:32:07 PM |
Glad you got some! This is a good | MWM | investorshub | 10/06/2010 7:31:01 PM |
Glad my measly early buys helped flip the switch. | aries4747 | investorshub | 10/06/2010 7:29:48 PM |
I've been waiting for a big day for | MWM | investorshub | 10/06/2010 7:22:43 PM |
Geez, thought you promised $SWTX was slow moving! | aries4747 | investorshub | 10/06/2010 7:21:12 PM |
$SWTX Kabooom! $2.25! | MWM | investorshub | 10/06/2010 7:20:12 PM |
$2.10 being cleared! | MWM | investorshub | 10/06/2010 6:38:52 PM |
News, Short Squeeze, Breakout and More Instantly...
SpringWorks Therapeutics Inc. Company Name:
SWTX Stock Symbol:
NYSE Market:
– Achieved $21.0 million in OGSIVEO ® (nirogacestat) net product revenue in the first quarter – – Received validation from the EMA for MAA of nirogacestat for the treatment of adults with desmoid tumors – – Initiated ...
– Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted for oral presentation – – Additional data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat) in adults with desmoid tumors also accepted for presentations at ASCO – STAMF...
STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company f...